Widespread use of Ozempic for weight loss could change how we view fatness

Don’t Call Me Resilient - Un podcast de The Conversation, Vinita Srivastava, Dannielle Piper, Krish Dineshkumar, Jennifer Moroz, Rehmatullah Sheikh, Kikachi Memeh, Ateqah Khaki, Scott White

In this episode of Don't Call Me Resilient, we are joined by fat and disability studies professor Fady Shanouda, who examines anti-fat bias in medicine. As the use of Ozempic, a drug for diabetes, slams into the mainstream as a weight-loss method, will the drug’s use impact our concept of fatness? And how does fatness intersect with race and class?

Visit the podcast's native language site